George F. Vande Woude
George F. Vande Woude
Verified email at
Cited by
Cited by
Met, metastasis, motility and more
C Birchmeier, W Birchmeier, E Gherardi, GF Vande Woude
Nature reviews Molecular cell biology 4 (12), 915-925, 2003
Identification of the Hepatocyte Growth Factor Receptor As the c-met Proto-Oncogene Product
DP Bottaro, JS Rubin, DL Faletto, AML Chan, TE Kmiecik, ...
Science 251 (4995), 802-804, 1991
Transformation of mammalian cells by constitutively active MAP kinase kinase
SJ Mansour, WT Matten, AS Hermann, JM Candia, S Rong, K Fukasawa, ...
Science 265 (5174), 966-970, 1994
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
NS Duesbery, CP Webb, SH Leppla, VM Gordon, KR Klimpel, ...
Science 280 (5364), 734-737, 1998
Molecular cloning of a new transforming gene from a chemically transformed human cell line
CS Cooper, M Park, DG Blair, MA Tainsky, K Huebner, CM Croce, ...
Nature 311 (5981), 29-33, 1984
Abnormal centrosome amplification in the absence of p53
K Fukasawa, T Choi, R Kuriyama, S Rulong, GFV Woude
Science 271 (5256), 1744-1747, 1996
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs
N Sagata, N Watanabe, GF Vande Woude, Y Ikawa
Nature 342 (6249), 512-518, 1989
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.
M Park, M Dean, K Kaul, MJ Braun, MA Gonda, G Vande Woude
Proceedings of the National Academy of Sciences 84 (18), 6379-6383, 1987
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes
N Sagata, M Oskarsson, T Copeland, J Brumbaugh, GFV Woude
Nature 335 (6190), 519-525, 1988
Mechanism of met oncogene activation
M Park, M Dean, CS Cooper, M Schmidt, SJ O'Brien, DG Blair, ...
Cell 45 (6), 895-904, 1986
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner
M Fiscella, HL Zhang, S Fan, K Sakaguchi, S Shen, WE Mercer, ...
Proceedings of the National Academy of Sciences 94 (12), 6048-6053, 1997
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer
JP Eder, GF Vande Woude, SA Boerner, PM LoRusso
Clinical Cancer Research 15 (7), 2207-2214, 2009
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
KA Furge, YW Zhang, GF Vande Woude
Oncogene 19 (49), 5582-5589, 2000
A cytoskeletal structure with associated polyribosomes obtained from HeLa cells
R Lenk, L Ransom, Y Kaufmann, S Penman
Cell 10 (1), 67-78, 1977
A closely linked genetic marker for cystic fibrosis
R White, S Woodward, M Leppert, P O'Connell, M Hoff, J Herbst, ...
Nature 318 (6044), 382-384, 1985
Activating mutations for the met tyrosine kinase receptor in human cancer
M Jeffers, L Schmidt, N Nakaigawa, CP Webb, G Weirich, T Kishida, ...
Proceedings of the National Academy of Sciences 94 (21), 11445-11450, 1997
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
GH Xiao, M Jeffers, A Bellacosa, Y Mitsuuchi, GF Vande Woude, JR Testa
Proceedings of the National Academy of Sciences 98 (1), 247-252, 2001
Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro
J Posada, N Yew, NG Ahn, GFV Woude, JA Cooper
Molecular and cellular biology, 1993
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
S Rong, S Segal, M Anver, JH Resau, GF Vande Woude
Proceedings of the National Academy of Sciences 91 (11), 4731-4735, 1994
Met and hepatocyte growth factor/scatter factor expression in human gliomas
S Koochekpour, M Jeffers, S Rulong, G Taylor, E Klineberg, EA Hudson, ...
Cancer research 57 (23), 5391-5398, 1997
The system can't perform the operation now. Try again later.
Articles 1–20